medline.ch Neurologie Alzheimer

	Longifolene mitigates amyloid beta induced neurotoxicity by acting on PI3K/AKT/NFÎºB pathway: Comprehensive in vitro, in vivo pharmacokinetics and pharmacodynamic studies for Alzheimer's disease. Eur J Pharmacol Thakkar A, Mote C, Gadade A, Dighe V, Kaur G, Vora A. PMID: 42425385 [PubMed - as supplied by publisher]
	Synaptic Dysfunction as a Major Driver in Alzheimer's Disease: Beyond the Amyloid Paradigm. Neurosci Biobehav Rev Mierzwa N, W. PMID: 42425281 [PubMed - as supplied by publisher]
	Recent advances in Alzheimer's disease: From molecular mechanisms to therapeutic strategies. Cell Rudman MD, Ulrich JD, Holtzman DM. PMID: 42425064 [PubMed - in process]
	The heat exposure, aging trajectories, and Alzheimer's disease (HEAT-AD) study protocol. PLoS One O'Shea DM, Chang LC, Chowdhury M, Cook DJ, Cresswell K, Minor BD, Mitsova D, Tourelle MS, Galvin JE, Besser LM. PMID: 42424329 [PubMed - indexed for MEDLINE]
	Metabolic risk and metabolic dysfunction-associated steatotic liver disease and steatohepatitis in cognitive decline: A retrospective cohort study. PLoS One Nasir AB, Kilani Y, Aldiabat M, Abdelghany O, Hafez Y, Desai N, Madi MY, Wade FG, Qureshi K, Frey LJ, Farmer AD, Syn WK. PMID: 42424274 [PubMed - indexed for MEDLINE]
	Autophagy in Alzheimer's disease: mechanisms, clinical trials, and horizons. Neurodegener Dis Tshimbombu TN, Thurmann KE, Decourt B, Nyalundja AD, Shardow SB, Amoako ME, Iragi GM, Mwambali JA, Sabbagh MN. PMID: 42424238 [PubMed - as supplied by publisher]
	Alzheimer Disease Biomarkers and Assisted Dying: When Diagnosis Becomes a Deadline. JAMA Lyndon S, Behlke LM, Urizar JC, Daffner KR. PMID: 42424076 [PubMed - as supplied by publisher]
	A real-world decision tree model based on Â¹â¸F-FDG PET/CT Z scores and Mini-Mental State Examination for differentiating mild cognitive impairment from clinically diagnosed Alzheimer disease. Ann Nucl Med Övüt AR, Toyran R, Bülbül NG, Urhan M. PMID: 42423959 [PubMed - as supplied by publisher]
	A nose-to-brain drug delivery system targeting mitochondrial dysfunction: application potential and future prospects of chitosan nanogels in Alzheimer's disease. Biomater Sci Huang Q, Zuo Y, Xie Y, Liu Z, Wang L, Xu H, Yu M, Liu C. PMID: 42423667 [PubMed - as supplied by publisher]
	Frailty as an underrepresented dimension in clinical trials of Alzheimer's disease therapies. J Alzheimers Dis Solfrizzi V, Imbimbo BP. PMID: 42423483 [PubMed - as supplied by publisher]
	Efficacy, safety and policy implications of anti-amyloid monoclonal antibodies for Alzheimer's disease: protocol for a living systematic review and meta-analysis. BJPsych Open Kim S, Oda H, Oyama R, Makishi R, Bade S, Bade S, Ally I, Iijima Y, Gibo Y, Minami K, Fukuzawa F, Sanji S, Inamine K, Kishi H, Huh S, Tanifuji T, Nagahiro M, Watanabe N. PMID: 42423023 [PubMed]
	Clinical, Radiological, and Immunohistological Distinctions Between Limbic-Predominant and Typical Alzheimer's Disease: A Systematic Review. Brain Behav Secco GL, Qureshi K, Shafeea MS, Karpinski PH, Wouters K, Merlim da Silva MC, Ganta SR, von Quednow E, Guzmán-Ríos ED, Brice KS, Dsouza M, Fernandes A Junior, Noori NN, Chaurasia B, Yangi K. PMID: 42422911 [PubMed - indexed for MEDLINE]
	Osteoimmuno-brain axis: a bridge connecting osteoporosis and cognitive decline and its clinical significance in dementia and Alzheimer's disease. Front Immunol Xu G, Cheng Z, Zhou Y, Guo L, Zhu H, Shen Z. PMID: 42421969 [PubMed - indexed for MEDLINE]
	Could the cognitive benefits of amyloid-beta clearance grow in time for Alzheimer's disease? Transl Psychiatry He CY, Wang XY, Fan J, Wang YN, Masters CL, Wang YJ. PMID: 42420256 [PubMed - as supplied by publisher]
	Dietary patterns and Alzheimer's disease: East-west perspectives and future intervention strategies. J Prev Alzheimers Dis Jiang W, Lin Y, Guo Q, Miao Y. PMID: 42419161 [PubMed - as supplied by publisher]
	Multicenter validation of plasma p-tau217/ amyloid beta 1-42 ratio in symptomatic Alzheimer's disease. Alzheimers Dement Moghekar AR, Rock JA, Mohs RC, Hansson O, Stomrud E, Palmqvist S, Mattsson-Carlgren N, Johnson SC, Zetterberg H, Radwan RR, Junfola J, Miller MC, Buitrago L, De Simone FI, Martin K, Dickson D, Benina N, Hawkins DM. PMID: 42418465 [PubMed - indexed for MEDLINE]
	Neurophysiological Differentiation of Conversion to Alzheimer's Disease: Longitudinal Changes in P300 Amplitude as an Indicator of Mild Cognitive Impairment Progression. Brain Behav Özbek Y, Yener GG. PMID: 42418307 [PubMed - indexed for MEDLINE]
	Advances in the Core Role and Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease. Brain Behav Gu T, Guo H, Guo Z, Hua S. PMID: 42418295 [PubMed - indexed for MEDLINE]
	A Narrative Review of Amyloid-Î² Monoclonal Antibodies for Alzheimer Disease: How Amyloid Species Engagement May Affect Clinical Outcomes. Neurologist Caselli RJ, Geldmacher DS, Schilling TB. PMID: 42418270 [PubMed - indexed for MEDLINE]
	Regulation of NLRP3 inflammasome signaling in Alzheimer's disease: emerging neuroprotective role of phytochemicals. Inflammopharmacology Gupta A, Singh S, Singh TD. PMID: 42417935 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 71292

Seite 1 von 3565

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung